🔎 Trials Near Me

홈 › 전이성 암 › 워싱턴 D.C.

워싱턴 D.C.의 전이성 암 임상 시험

전이성 암 관련 연구 24개가 워싱턴 D.C. 내 여러 지역에서 참여자를 모집하고 있습니다.

워싱턴 D.C.의 도시

공식 연구 텍스트(영어)

A Study of ASP3082 in Adults With Advanced Solid Tumors

  • Georgetown University Hospital, Washington D.C.
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  • Georgetown University, Washington D.C.
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06943755

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • Johns Hopkins Sibley Memorial Hospital, Washington D.C.
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07277413

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • The George Washington Medical facility Associates, Washington D.C.
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07007559

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06989437

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT05118789

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • MedStar Washington Hospital Center, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • MedStar Washington Hospital Center, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

  • MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06863272

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

  • Clinical Study Site, Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  • Avenzo Therapeutics Recruiting Site, Washington D.C.
피험자 모집 중1/2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07038343

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

  • Research Site, Washington D.C.
피험자 모집 중2상
18세 ~ 130세 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06792695

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05919264

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Washington D.C.
피험자 모집 중3상
18세 이상 · 여성 · 2026. 7. 29. 업데이트됨 · NCT07044336

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

  • George Washington University, Washington D.C.
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 7. 14. 업데이트됨 · NCT05533697

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

  • MedStar Washington Hospital Center, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 6. 16. 업데이트됨 · NCT05208047

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 5. 27. 업데이트됨 · NCT05384626

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

  • Cancer Support Community Research & Training Institute, Washington D.C.
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT02333604

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • The George Washington University, Washington D.C.
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT06064877

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  • Washington DC VA Medical Center, Washington, DC, Washington D.C.
피험자 모집 중2/3상
18세 이상 · 남성 · 2026. 4. 8. 업데이트됨 · NCT04787744

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • Georgetown University Medical Center, Washington D.C.
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 4. 2. 업데이트됨 · NCT06581406

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

  • Georgetown University Medical Center, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 25. 업데이트됨 · NCT06521554

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

  • The George Washington University Cancer Center (site 212), Washington D.C.
피험자 모집 중1/2상
18세 ~ 80세 · 모든 성별 · 2025. 12. 11. 업데이트됨 · NCT03556228

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.